Endermologie Versus Negative Pressure Therapy on Postmastectomy Lymphedema
Mastectomy; Lymphedema
About this trial
This is an interventional treatment trial for Mastectomy; Lymphedema
Eligibility Criteria
Inclusion Criteria: Only females will participate in the study. Patients' age was ranged between 40-60 years. All patients will suffer from post mastectomy lymphedema. All patients have a modified radical mastectomy. All patients suffer from grade II lymphedema without skin changes one year post mastectomy(as defined by the International Society of Lymphology). All patients are right-dominant hand. All patients enrolled to the study will have their informed consent. Exclusion Criteria: The potential participants will be excluded if they meet one of the following criteria: primary lymphedema. Diabetes mellitus. Pregnancy. Recurrent cancer. Current or recent cellulitis. Current metastases. Venous thrombosis. Photosensitivity. Phlebitis in development stage. Infection. Receiving anti-coagulant treatment.
Sites / Locations
- Outpatient clinic, Faculty of Physical Therapy, Cairo university
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Group A (endermologie group)
Group B (Negative pressure therapy group)
This group includes 34 patients who will receive 30 min Endermologie 3 times per week in addition to their physical therapy program (active range of motion and elevation); hygiene and skin care for 6 weeks.
This group includes34 patients who will receive 30min negative pressure therapy 3 times per week in addition to their physical therapy program (active range of motion and elevation); hygiene and skin care for 6 weeks